ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Utah » Internal Medicine

Top Internal Medicine Prescribers in Utah

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JEFFREY JOHNSON MD

Internal Medicine

9,275

$601K

439
388 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $62

JEFFREY TWITCHELL M.D.

Internal Medicine

9,150

$573K

444
392 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $62

J PARKINSON DO

Internal Medicine

8,804

$680K

615
545 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$77
Average prescription price

Avg: $62

KENT MARSHALL MD

Internal Medicine

8,697

$531K

438
383 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $62

NITA WEBER DO

Internal Medicine

8,673

$445K

329
258 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $62

KEVIN JOHNSON M.D.

Internal Medicine

8,665

$497K

370
320 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $62

ALISON SCHLISMAN MD

Internal Medicine

8,628

$498K

443
427 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $62

JEFFREY STRONG MD

Internal Medicine

8,556

$502K

395
348 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $62

LEIGH THOMPSON MD

Internal Medicine

8,514

$349K

256
184 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $62

KENT ROMNEY MD

Internal Medicine

8,492

$452K

530
474 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $62

WILLIAM BARNEY MD

Internal Medicine

8,356

$434K

415
378 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $62

DAVID ZACKRISON M.D.

Internal Medicine

8,334

$444K

357
306 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $62

BRUCE HENDRIX MD

Internal Medicine

8,291

$443K

426
361 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $62

THOMAS BARMAN M.D.

Internal Medicine

8,246

$406K

446
402 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $62

DAVID HORSLEY MD

Internal Medicine

8,219

$579K

417
384 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $62

TIMOTHY JOHNSON MD

Internal Medicine

8,134

$402K

470
402 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $62

GLEN BIDDULPH M.D.

Internal Medicine

8,113

$602K

510
460 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $62

KENT SMITH MD

Internal Medicine

8,079

$373K

377
330 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $62

THOMAS JONES MD

Internal Medicine

8,073

$453K

536
496 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $62

YUN LING MD

Internal Medicine

8,022

$409K

518
428 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $62

PATRICK MCDERMOTT MD

Internal Medicine

8,017

$461K

424
383 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $62

JOSEPH WOOLLEY M.D.

Internal Medicine

8,015

$549K

528
479 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $62

DANIEL YARRISH M.D.

Internal Medicine

8,000

$429K

398
343 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $62

GARRY MILLER D.O.

Internal Medicine

7,967

$464K

449
390 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $62

KAVITA WILLESEN MD

Internal Medicine

7,940

$521K

553
476 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank